Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the abbott alinity c alkaline phosphatase assay is used for the quantitation of alkaline phosphatase in human serum or plasma on the alinity c analyzer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the abbott alinity c ict (integrated chip technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine on the alinity c analyzer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the abbott alinity c ultra hdl assay is used for the quantitation of high density lipoprotein (hdl) cholesterol in human serum or plasma on the alinity c analyzer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect 25-oh vitamin d assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of 25-hydroxyvitamin d (25-oh vitamin d) in human serum and plasma. the architect 25-oh vitamin d assay is to be used as an aid in the assessment of vitamin d sufficiency.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect anti-hbe assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of antibody to hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the architect clinical chemistry analyzers, which include architect c4000, c8000, and c16000 analyzers, are designed to perform automated chemistry tests, utilizing photometric and potentiometric technologies to measure the concentration of analytes in samples. the modular design of the architect family of analyzers allows multiple processing modules, which perform all sample processing activities, to be physically joined to form a single workstation or system. the selection of processing module(s) determines the configuration of the system. the analyzers are intended for in vitro diagnostic use only.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the magnesium assay is used for the quantization of magnesium in human serum, plasma, or urine.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbeag assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system. the architect hbeag assay can also be used for the quantitative determination of hbeag. refer to architect hbeag quantitative calibrators package insert (7p24-01) for instructions and further information.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbsag confirmatory v.1 assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma by means of specific antibody neutralization. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the architect hbsag qualitative ii assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma including speciments collected post-mortem (non-heart-beating). the architect hbsag qualitative ii assay is intended to be used as an aid in the diagnosis of hbv infection and as a screening test for donated blood and plasma to prevent transmission of hbv to recipients of blood, blood components, cells, tissues and organs. the architect hbsag qualitative ii confirmatory assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected post-mortem (non-heart-beating) by means of specific antibody neutralization. it is intended to be used for the confirmation of samples found to be repeatedly reactive by architect hbsag qualitative ii.